Clinical trial payment automation solutions provider Greenphire has expanded its global travel solution, ConneX, to include additional in-market support and travel visa fulfilment services.

ConneX is designed to meet global clinical trials retention goals by providing concierge travel services, which deliver a better experience for patients, caregivers, families, and sites. It is used by over 40 pharmaceutical companies and contract research organisations (CROs).

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The travel solution has recently been enhanced to provide in-market, local language, and time zone travel arrangements for global clinical trials market.

Greenphire CEO Jim Murphy said: “We developed ConneX to eliminate the logistical and financial barriers that often hinder participants from enrolling or staying enrolled in a clinical trial, while also removing the administrative burden of travel arrangement from site staff.

“With its ability to integrate with our ClinCard solution, the most widely adopted participant payment and reimbursement technology, ConneX also provides sponsors and CROs with a comprehensive financial view, for enhanced predictability and cost analysis.”

ConneX can be customised to accommodate the logistical requirements of each participant, providing peace-of-mind to patients and caregivers while away from home.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

As part of the solution expansion, Greenphire has launched visa and companion care services in ConneX. This feature enables the company to coordinate the visa securing process of a participant.

ConneX is also enhanced with a companion care offering solution, which allows a qualified companion to travel with a participant attending a clinical trial.

The travel solution is claimed to provide an improved clinical trial experience and added patient convenience and retention, benefitting all stakeholders.

In July last year, CRO Atlantic Research Group announced that it is set to implement Greenphire’s ClinCard and ConneX solutions to enhance the clinical trial experience for patients and sites.

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Science 37 has won the Research and Development Award in the Site Innovation category for its FDA inspected Direct-to-Patient Site model, delivering nationwide access, faster enrollment and higher retention. Explore how its virtual-first, in home approach is reshaping trial operations and accelerating time to data-driven decisions..

Discover the Impact